Stockholders' Equity - Common Purchase Agreement (Details) - USD ($) $ in Thousands					1 Months Ended	3 Months Ended	9 Months Ended
	Nov. 05, 2024	Aug. 14, 2023	Mar. 29, 2023	Mar. 27, 2023	Nov. 06, 2024	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023
Stockholders Equity Note [Line Items]
Proceeds from exercise of warrants							$ 259	$ 35,004
Common Purchase Agreement \| Subsequent Event
Stockholders Equity Note [Line Items]
Warrant exercise period					21 days
Preferred Purchase Agreement
Stockholders Equity Note [Line Items]
Minimum revenue requirement							10,000
Minimum revenue requirement achieved						$ 10,000
Tranche A Warrants \| Common Purchase Agreement
Stockholders Equity Note [Line Items]
Number of exercisable common warrants (in shares)		31,110		31,110
Aggregate exercise price of preferred warrants			$ 100
Tranche B Warrants \| Common Purchase Agreement
Stockholders Equity Note [Line Items]
Number of exercisable common warrants (in shares)			16,666	16,666
Aggregate exercise price of preferred warrants			$ 100
Warrants exercisable, period			21 days
Tranche B Warrants \| Common Purchase Agreement \| Subsequent Event
Stockholders Equity Note [Line Items]
Proceeds from exercise of warrants					$ 100
Preferred Tranche B Warrant \| Preferred Purchase Agreement
Stockholders Equity Note [Line Items]
Aggregate exercise price of preferred warrants							$ 24,700
Warrant exercise period							21 days
Class of warrant or right, number of warrants exercised (in shares)							250
Proceeds from exercise of warrants							$ 300
Preferred Tranche B Warrant \| Preferred Purchase Agreement \| Subsequent Event
Stockholders Equity Note [Line Items]
Class of warrant or right, number of warrants exercised (in shares)	24,900				16,666
Proceeds from exercise of warrants	$ 24,900